Proliferation and wound healing of vascular cells trigger the generation of extracellular reactive oxygen species and LDL oxidation

Free Radical Biology and Medicine

Volumn 35, Issue 12, 2003, Pages 1589-1598

  Duval, Carine ^a   Cantero, Anne Valerie ^a   Auge, Nathalie ^a   Mabile, Laurence ^a   Thiers, Jean Claude ^a   Negre Salvayre, Anne ^a   Salvayre, Robert ^a  

^a CHU RANGUEIL   (France)

Author keywords

Atherosclerosis; Confluence; Free radicals; Healing; LDL oxidation; Proliferation; Reactive oxygen species; Superoxide anion

Indexed keywords

HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; OXYGEN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTACT INHIBITION; CONTROLLED STUDY; DATA ANALYSIS; DNA SYNTHESIS; ENDOTHELIUM CELL; FEMORAL ARTERY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID OXIDATION; MITOGENESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WOUND HEALING;

EID: 0346996627     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.09.008     Document Type: Article

References (46)

1. Stary H.C. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the forty years of life. Eur. Heart J. 11:1990;3-19.
2. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
3. Chang E., Harley C.B. Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. USA. 92:1995;11190-11194.
4. Brunet A., Pouyssegur J. Mammalian MAP kinase modules how to transduce specific signals . Essays Biochem. 32:1997;1-16.
5. Malarkey K., Belham C.M., Paul A., Graham A., McLees A., Scott P.H., Plevin R. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem. J. 309:1995;361-375.
6. Seger R., Krebs E. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
7. Irani K. Oxidant signaling in vascular cell growth, death, and survival. Circ. Res. 87:2000;179-183.
8. Napoli C., De Nigris F., Palinski W. Multiple role of reactive oxygen species in the arterial wall. J. Cell. Biochem. 82:2001;674-682.
9. Sorescu D., Szocs K., Griendling K.K. NAD(P)H oxidases and their relevance to atherosclerosis. Trends Cardiovasc. Med. 11:2001;124-131.
10. Kamata H., Hirata H. Redox regulation of cellular signalling. Cell. Signal. 11:1999;1-14.
11. Sauer H., Wartenberg M., Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem. 11:2001;173-186.
12. Martindale J.L., Holbrook N.J. Cellular response to oxidative stress signaling for suicide and survival . J. Cell. Physiol. 192:2002;1-15.
13. Wolin M.S. Interactions of oxidants with vascular signaling systems. Arterioscler. Thromb. Vasc. Biol. 20:2000;1430-1442.
14. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis implications for the oxidized LDL hypothesis . Atherosclerosis. 141:1998;1-15.
15. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular disease. Circ. Res. 87:2000;840-844.
16. Ignarro L.J. Physiology and pathophysiology of nitric oxide. Kidney Int. Suppl. 55:1996;S2-S5.
17. Ylä-Herttuala, R.; Rosenfeld, M. E.; Parthasarathy, S.; Glass, C. K.; Sigal, E.; Witzum, J. L.; Steinberg, D. Co-localization of 15-lipoxygenase mRNA and protein with epitopes of oxidized LDL in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 87:6959-6953; 1990.
18. Kuhn H., Heydeck D., Hugou I., Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherosclerosis. J. Clin. Invest. 99:1997;888-893.
19. Fleming I., Michaelis U.R., Bredenkotter D., Fisslthaler B., Dehghani F., Brandes R.P., Busse R. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ. Res. 88:2001;44-51.
20. Hajjar D.P., Haberland M.E. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J. Biol. Chem. 272:1997;22975-22978.
21. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of LDL that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
22. Jürgens G., Hoff H.F., Chilsolm G.M., Esterbauer H. Modification of human serum low density lipoprotein by oxidation - characterization and pathophysiological implications. Chem. Phys. Lipids. 45:1987;315-336.
23. Arnal J.F., Tack I., Besombes J.P., Pipy B., Negre-Salvayre A. Nitric oxide and superoxide anion production during endothelial cell proliferation. Am. J. Physiol. 271:1996;C1521-C1526.
24. Turner C.P., Toye A.M., Jones O.T. Keratinocyte superoxide generation. Free Radic. Biol. Med. 24:1998;401-407.
25. Auge N., Andrieu N., Negre-Salvayre A., Thiers J.C., Levade T., Salvayre R. The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J. Biol. Chem. 271:1996;19251-19255.
26. Mabile L., Meilhac O., Escargueil-Blanc I., Troly M., Pieraggi M.T., Salvayre R., Negre-Salvayre A. Mitochondrial function is involved in LDL oxidation mediated by human cultured endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17:1997;1575-1582.
27. Yagi K. Lipid peroxides and human diseases. Chem. Phys. Lipids. 45:1987;337-351.
28. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. J. Immunol. Methods. 89:1986;371-377.
29. Vieira O., Escargueil-Blanc I., Jurgens G., Borner C., Almeida L., Salvayre R., Negre-Salvayre A. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway potential role in oxidized LDL-induced apoptosis . FASEB J. 14:2000;532-542.
30. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
31. 2 formation relationship with energy conservation . FEBS Lett. 33:1973;84-87.
32. Negre-Salvayre A., Hirtz C., Carrera G., Cazenave R., Troly M., Salvayre R., Pénicaud L., Casteilla L. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 11:1997;809-815.
33. Suc I., Meilhac O., Lajoie-Mazenc I., Vandaele J., Jurgens G., Salvayre R., Negre-Salvayre A. Activation of EGF receptor by oxidized LDL. FASEB J. 12:1998;665-671.
34. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
35. Heinecke J.W., Baker L., Rosen H., Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77:1986;757-761.
36. Pani G., Colavitti R., Bedogni B., Anzevino R., Borrello S., Galeotti T. A redox signaling mechanism for density-dependent inhibition of cell growth. J. Biol. Chem. 275:2000;38891-38899.
37. Sorby M., Ostman A. Protein-tyrosine phosphatase-mediated decrease of epidermal growth factor and platelet-derived growth factor receptor tyrosine phosphorylation in high cell density cultures. J. Biol. Chem. 271:1996;10963-10966.
38. Vinals F., Pouyssegur J. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Mol. Cell. Biol. 19:1999;2763-2772.
39. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 11:1997;118-124.
40. Mugge A. The role of reactive oxygen species in atherosclerosis. Z. Kardiol. 87:1998;851-864.
41. Harats D., Shaish A., George J., Mulkins M., Kurihara H., Levkovitz H., Sigal E. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20:2000;2100-2105.
42. Mehrabian M., Allayee H., Wong J., Shi W., Wang X.P., Shaposhnik Z., Funk C.D., Lusis A.J., Shih W. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91:2002;120-126.
43. Parthasarathy S., Wieland E., Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 86:1989;1046-1050.
44. Cathcart M.K., Li Q., Chisolm G.M. Lipoprotein receptor interactions are not required for monocyte oxidation of LDL. J. Lipid Res. 36:1995;1857-1865.
45. Tangirala R.K., Mol M.J., Steinberg D. Macrophage oxidative modification of low density lipoprotein occurs independently of its binding to the low density lipoprotein receptor. J. Lipid Res. 37:1996;835-843.
46. Zhu H., Takahashi Y., Xu W., Kawajiri H., Murakami T., Yamamoto M., Iseki S., Iwasaki T., Hattori H., Yoshimoto T. Low density lipoprotein receptor-related protein-mediated membrane translocation of 12/15-lipoxygenase is required for oxidation of low density lipoprotein by macrophages. J. Biol. Chem. 278:2003;13350-13355.